- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
NYU-Led Study Finds Removal of Gene Prevents Development of Aggressive Pancreatic Cancer in Mice
A study led by researchers from the NYU School of Medicine and the University of Michigan has found that the action of a gene called ATDC is required for the development of pancreatic cancer.
A study led by researchers from the NYU School of Medicine and the University of Michigan has found that the action of a gene called ATDC is required for the development of pancreatic cancer. These findings were demonstrated in a study of mice and human patient samples.
The research builds upon the theory that many cancer arise when adults cells switch back into more “primitive,” high-growth cell types, like those that drive fetal development. When this reversion happens in the presence of other genetic mistakes, a repair process meant to start and stop quickly remains unchecked.
